I agree that this site is using cookies. You can find further informations here.
X
Laurens E. Franssen
493  results:
Search for persons X
?
1

Midostaurin as the Most Likely Cause of Bilateral Adrenal M..:

Schutte, Tim ; Stege, Claudia A. M. ; Smits, Mark M....
Clinical Drug Investigation.  42 (2022)  9 - p. 791-797 , 2022
Link: https://doi.org/10.1007/..
 
?
2

Resistance Mechanisms towards CD38−Directed Antibody Therap..:

Franssen, Laurens E. ; Stege, Claudia A. M. ; Zweegman, Sonja..
Journal of Clinical Medicine.  9 (2020)  4 - p. 1195 , 2020
Link: https://doi.org/10.3390/..
 
?
3

Immunotherapy in myeloma: how far have we come?:

Franssen, Laurens E. ; Mutis, Tuna ; Lokhorst, Henk M..
Therapeutic Advances in Hematology.  10 (2019)  - p. 204062071882266 , 2019
Link: https://doi.org/10.1177/..
 
?
4

Lenalidomide combined with low-dose cyclophosphamide and pr..:

Franssen, Laurens E. ; Nijhof, Inger S. ; Bjorklund, Chad C....
Oncotarget.  9 (2018)  74 - p. 34009-34021 , 2018
Link: https://doi.org/10.18632..
 
?
5

Outcome of allogeneic transplantation in newly diagnosed an..:

Franssen, Laurens E. ; Raymakers, Reinier A. P. ; Buijs, Arjan...
European Journal of Haematology.  97 (2016)  5 - p. 479-488 , 2016
Link: https://doi.org/10.1111/..
 
?
6

Resistance Mechanisms Towards CD38−Directed Antibody Therap..:

Laurens E. Franssen ; Claudia A.M. Stege ; Sonja Zweegman..
https://www.mdpi.com/2077-0383/9/4/1195.  , 2020
Link: https://doi.org/10.3390/..
 
?
7

Resistance Mechanisms towards CD38−Directed Antibody Therap..:

Laurens E. Franssen ; Claudia A. M. Stege ; Sonja Zweegman..
Oncology.  , 2020
Link: https://doi.org/10.3390/..
 
?
8

Immunotherapy in myeloma: how far have we come?:

Laurens E. Franssen ; Tuna Mutis ; Henk M. Lokhorst.
https://doi.org/10.1177/2040620718822660.  , 2019
Link: https://doi.org/10.1177/..
 
?
9

Immunotherapy in myeloma:how far have we come?:

Franssen, Laurens E ; Mutis, Tuna ; Lokhorst, Henk M.
Franssen , L E , Mutis , T , Lokhorst , H M & van de Donk , N W C J 2019 , ' Immunotherapy in myeloma : how far have we come? ' , THERAPEUTIC ADVANCES IN HEMATOLOGY , vol. 10 , pp. 2040620718822660 . https://doi.org/10.1177/2040620718822660.  , 2019
Link: https://research.vumc.nl..
 
?
10

Immunotherapy in myeloma: how far have we come?:

Franssen, Laurens E ; Mutis, Tuna ; Lokhorst, Henk M.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348514/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
11

Cereblon loss and up-regulation of c-Myc are associated wit..:

Franssen, Laurens E ; Nijhof, Inger S ; Couto, Suzana...
0390-6078.  , 2018
Link: https://dspace.library.u..
 
?
12

Lenalidomide combined with low-dose cyclophosphamide and pr..:

Franssen, Laurens E ; Nijhof, Inger S ; Bjorklund, Chad C...
1949-2553.  , 2018
Link: https://dspace.library.u..
 
?
13

Cereblon loss and up-regulation of c-Myc are associated wit..:

Franssen, Laurens E ; Nijhof, Inger S ; Couto, Suzana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068039/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
14

Cereblon loss and up-regulation of c-Myc are associated wit..:

Franssen, Laurens E ; Nijhof, Inger S ; Couto, Suzana...
Franssen , L E , Nijhof , I S , Couto , S , Levin , M-D , Bos , G M J , Broijl , A , Klein , S K , Ren , Y , Wang , M , Koene , H R , Bloem , A C , Beeker , A , Faber , L M , van der Spek , E , Raymakers , R , Leguit , R J , Sonneveld , P , Zweegman , S , Lokhorst , H , Mutis , T , Thakurta , A , Qian , X & van de Donk , N W C J 2018 , ' Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients ' , Haematologica-the Hematology Journal , vol. 103 , no. 8 , pp. E368-E371 . https://doi.org/10.3324/haematol.2017.186601.  , 2018
Link: https://cris.maastrichtu..
 
?
15

Cereblon loss and up-regulation of c-Myc are associated wit..:

Franssen, Laurens E ; Nijhof, Inger S ; Couto, Suzana...
Franssen , L E , Nijhof , I S , Couto , S , Levin , M D , Bos , G M J , Broijl , A , Klein , S K , Ren , Y , Wang , M , Koene , H R , Bloem , A C , Beeker , A , Faber , L M , van der Spek , E , Raymakers , R , Leguit , R J , Sonneveld , P , Zweegman , S , Lokhorst , H , Mutis , T , Thakurta , A , Qian , X & van de Donk , N W C J 2018 , ' Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients ' , Haematologica , vol. 103 , no. 8 , pp. e368-e371 . https://doi.org/10.3324/haematol.2017.186601.  , 2018
Link: https://research.vumc.nl..
 
1-15